Valuation: Medios AG

Capitalization 349M 410M 326M 307M 565M 37.1B 617M 3.8B 1.48B 17.49B 1.54B 1.5B 63.8B P/E ratio 2025 *
13.3x
P/E ratio 2026 * 10.4x
Enterprise value 461M 541M 430M 405M 745M 48.98B 814M 5.02B 1.95B 23.09B 2.03B 1.99B 84.24B EV / Sales 2025 *
0.23x
EV / Sales 2026 * 0.2x
Free-Float
92.4%
Yield 2025 *
-
Yield 2026 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day+1.79%
1 week-5.52%
Current month-7.07%
1 month-8.31%
3 months-6.56%
6 months+20.85%
Current year+3.48%
More quotes
1 week 13.32
Extreme 13.32
14.84
1 month 13.32
Extreme 13.32
15.2
Current year 9.98
Extreme 9.98
16.06
1 year 9.98
Extreme 9.98
16.06
3 years 9.98
Extreme 9.98
21.8
5 years 9.98
Extreme 9.98
41.6
10 years 7.41
Extreme 7.41
42
More quotes
Manager TitleAgeSince
Chief Executive Officer 58 2020-12-31
Director of Finance/CFO 54 2021-09-30
Investor Relations Contact - -
Director TitleAgeSince
Chairman 52 2014-11-06
Director/Board Member 63 2016-09-13
Director/Board Member 64 2016-09-13
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
+1.79%-5.52%+15.74%-30.06% 410M
+1.80%+1.70%+30.21%+186.49% 920B
+0.75%+4.78%+44.31%+18.06% 510B
-0.29%-1.22%+28.81%+35.52% 395B
-0.35%+1.90%+25.12%+3.11% 340B
-1.12%-1.09%+28.43%+18.70% 278B
-0.45%-1.48%+20.24%+24.41% 254B
+1.30%+0.58%-1.67%-9.57% 249B
+0.45%+3.73%-57.41%-30.85% 224B
+0.11%-3.68%+17.41%+16.70% 171B
Average +0.40%-0.03%+15.12%+23.25% 334.24B
Weighted average by Cap. +0.55%+1.15%+21.86%+60.08%
See all sector performances

Financials

2025 *2026 *
Net sales 2.01B 2.36B 1.87B 1.76B 3.25B 213B 3.55B 21.88B 8.49B 101B 8.84B 8.65B 367B 2.06B 2.42B 1.92B 1.81B 3.33B 219B 3.64B 22.46B 8.71B 103B 9.07B 8.88B 377B
Net income 25.97M 30.48M 24.26M 22.82M 42.02M 2.76B 45.9M 283M 110M 1.3B 114M 112M 4.75B 32.99M 38.72M 30.82M 28.99M 53.38M 3.51B 58.31M 360M 140M 1.65B 145M 142M 6.03B
Net Debt 112M 131M 104M 98.24M 181M 11.88B 198M 1.22B 473M 5.6B 492M 482M 20.44B 71.65M 84.1M 66.93M 62.97M 116M 7.62B 127M 781M 303M 3.59B 316M 309M 13.1B
More financial data * Estimated data
Logo Medios AG
Medios AG, formerly Crevalis Capital AG, is a Germany-based company offering solutions in pharma industry. The Company covers relevant aspects of supply chain like from pharmaceutical supply and manufacture of patient-specific therapies, including blistering and others. It operates in two segments Pharmaceutical supply which focuses on pharmaceutical wholesale with finished specialty pharma (high-priced drugs for rare and chronic diseases) medications including oncology, neurology, autoimmunology, ophthalmology, infectiology, hemophilia along with offering finished medicinal products; Patient-specific therapies focusing on pharmaceutical manufacturing of patient-specific preparations such as Cytostatic infusions, Antibody therapies, Virostatic and antibiotic medications, Parenteral nutrition solutions, Investigational medicinal products are among others. Its products and services include Patient health & protection and procedures & processes for patient care and digitalization of data.
Employees
999
More about the company
Date Price Change Volume
25-12-12 13.68 -1.72% 80,639
25-12-11 13.92 -2.66% 15,973
25-12-10 14.30 -1.38% 31,090
25-12-09 14.50 +0.97% 20,912
25-12-08 14.36 -0.83% 51,082

Delayed Quote Xetra, December 12, 2025 at 11:35 am EST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
13.68EUR
Average target price
23.40EUR
Spread / Average Target
+71.05%
Consensus

Quarterly revenue - Rate of surprise